<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vtio</journal-id><journal-title-group><journal-title xml:lang="ru">Вестник трансплантологии и искусственных органов</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal of Transplantology and Artificial Organs</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-1191</issn><publisher><publisher-name>Academician V.I.Shumakov National Medical Research Center of Transplantology and Artificial Organs", Ministry of Health of the Russian Federation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15825/1995-1191-2014-4-72-77</article-id><article-id custom-type="elpub" pub-id-type="custom">vtio-475</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Регенеративная медицина и клеточные технологии</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Regenerative Medicine and Cell Technologies</subject></subj-group></article-categories><title-group><article-title>ЭФФЕКТ НИТРОГЛИЦЕРИНА НА ПРОЛИФЕРАТИВНЫЙ И МИГРАЦИОННЫЙ ПОТЕНЦИАЛ МОНОНУКЛЕАРНЫХ КЛЕТОК ПЕРИФЕРИЧЕСКОЙ КРОВИ</article-title><trans-title-group xml:lang="en"><trans-title>THE EFFECTS OF NITROGLYCERIN ON THE PROLIFERATIVE AND MIGRATORY POTENTIAL OF PERIPHERAL BLOOD MONONUCLEAR CELLS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бондаренко</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Bondarenko</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>630117, г. Новосибирск, ул. Тимакова, 2. Тел. 8 (906) 193-87-88</p></bio><email xlink:type="simple">bond802888@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лыков</surname><given-names>А. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Lykov</surname><given-names>A. P.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ким</surname><given-names>И. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Kim</surname><given-names>I. I.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Повещенко</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Poveschenko</surname><given-names>O. V.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Повещенко</surname><given-names>А. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Poveschenko</surname><given-names>A. F.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Покушалов</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Pokushalov</surname><given-names>E. A.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Романов</surname><given-names>А. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Romanov</surname><given-names>A. B.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Коненков</surname><given-names>В. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Konenkov</surname><given-names>V. I.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Караськов</surname><given-names>А. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Karaskov</surname><given-names>A. M.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Лаборатория клеточных технологий ФГБУ «Научно-исследовательский институт клинической&#13;
и экспериментальной лимфологии» СО РАМН, Новосибирск, Российская Федерация&#13;
&#13;
Центр новых технологий, лаборатория клеточных технологий ФГБУ «Новосибирский научно-исследовательский институт патологии кровообращения им. Е.Н. Мешалкина» МЗ РФ,&#13;
Новосибирск, Российская Федерация</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Laboratory of Cell Technologies, FSBI «Research Institute of Clinical and Experimental Lymphology», Novosibirsk, Russian Federation&#13;
&#13;
Center of new technologies, laboratory of the cellular technologies, FSBI «E.N. Meshalkin Research Institute of Circulation Pathology», Novosibirsk, Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Центр новых технологий, лаборатория клеточных технологий ФГБУ «Новосибирский научно-исследовательский институт патологии кровообращения им. Е.Н. Мешалкина» МЗ РФ,&#13;
Новосибирск, Российская Федерация</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Center of new technologies, laboratory of the cellular technologies, FSBI «E.N. Meshalkin Research Institute of Circulation Pathology», Novosibirsk, Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>15</day><month>01</month><year>2015</year></pub-date><volume>16</volume><issue>4</issue><fpage>72</fpage><lpage>77</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Бондаренко Н.А., Лыков А.П., Ким И.И., Повещенко О.В., Повещенко А.Ф., Покушалов Е.А., Романов А.Б., Коненков В.И., Караськов А.М., 2014</copyright-statement><copyright-year>2014</copyright-year><copyright-holder xml:lang="ru">Бондаренко Н.А., Лыков А.П., Ким И.И., Повещенко О.В., Повещенко А.Ф., Покушалов Е.А., Романов А.Б., Коненков В.И., Караськов А.М.</copyright-holder><copyright-holder xml:lang="en">Bondarenko N.A., Lykov A.P., Kim I.I., Poveschenko O.V., Poveschenko A.F., Pokushalov E.A., Romanov A.B., Konenkov V.I., Karaskov A.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.transpl.ru/vtio/article/view/475">https://journal.transpl.ru/vtio/article/view/475</self-uri><abstract><sec><title>Цель</title><p>Цель. Изучить эффекты влияния нитроглицерина на пролиферативную и миграционную активность мононуклеарных клеток и эндотелиальных прогениторных клеток у пациентов с хронической сердечнойнедостаточностью.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Пролиферативный потенциал мононуклеарных клеток периферической крови у доноров и пациентов изучали в МТТ-тесте в присутствии 50 и 100 мкг/мл нитроглицерина, пролиферацию и миграцию эндотелиальных прогениторных клеток пациентов оценивали по изменению клеточного импеданса в режиме реального времени в присутствии различных доз нитроглицерина.</p></sec><sec><title>Результаты</title><p>Результаты. Показано, что нитроглицерин снижает пролиферативную активность in vitro мононуклеарных клеток пациентов с хронической сердечной недостаточностью, как спонтанную, так и стимулированную Конканавалин А. Мононуклеарные клетки периферической крови пациентов с хронической сердечной недостаточностью, полученные после процедуры мобилизации гранулоцитарным колониестимулирующим фактором, отвечают увеличением пролиферативной активности на нитроглицерин в дозе 50 мкг/мл, а при дозе 100 мкг/мл – подавлением пролиферативной активности. Мононуклеары условно здоровых доноров в ответ на стимуляцию нитроглицерином отвечают активацией пролиферативного потенциала. Показан стимулирующий эффект нитроглицерина на пролиферативный и миграционный потенциал эндотелиальных прогениторных клеток.</p></sec><sec><title>Заключение</title><p>Заключение. Установлен разнонаправленный и дозозависимый эффект нитроглицерина на различные типы клеток человека in vitro.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim. To study the effects of nitroglycerin on proliferative and migratory activity of mononuclear cells and endothelial progenitor cells in patients with chronic heart failure.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. Proliferative potential of peripheral blood mononuclear cells in donors and patients were studied in MTT-test in the presence of 50 and 100 mg/ml nitroglycerin. Proliferation and migration of endothelial progenitor cells in patients were evaluated by changes in the cell impedance in real-time in the presence of various doses of nitroglycerin.</p></sec><sec><title>Results</title><p>Results. It is shown that nitroglycerin reduces in vitro both spontaneous and Concanavalin A stimulated proliferative activity of mononuclear cells in patients with chronic heart failure. Peripheral blood mononuclear cells in patients with chronic heart failure, obtained after procedure of mobilization by granulocyte colony-stimulating factor respond to nitroglycerin dose of 50 mg/ml with the increased proliferative activity, and with the suppressed proliferative activity to nitroglycerin dose of 100 mg/ml. Mononuclear cells of healthy donors respond to 50 mg/ml of nitroglycerin with the activation of proliferative capacity, but at a dose of 100 mg/ml spontaneous proliferative activity of mononuclear cells inhibit. It is also shown that the presence of nitroglycerin in medium dose in stimulating test leads to the inhibition of mononuclear cells proliferation from healthy donors. It is shown the stimulating effect of nitroglycerin on proliferative and migration potential of endothelial progenitor cells.</p></sec><sec><title>Conclusion</title><p>Conclusion. Multidirectional and dose-dependent effects of nitroglycerin to the various types of human cells in vitro were observed.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>ишемическая болезнь сердца</kwd><kwd>нитроглицерин</kwd><kwd>мононуклеарные клетки</kwd><kwd>эндотелиальные прогениторные клетки</kwd></kwd-group><kwd-group xml:lang="en"><kwd>coronary heart disease</kwd><kwd>nitroglycerin</kwd><kwd>mononuclear cells</kwd><kwd>endothelial progenitor cells</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Meunzel T. Does nitroglycerin therapy hit the endothelium? Journal of the American College of Cardiology. 2001; 38: 1102–1105.</mixed-citation><mixed-citation xml:lang="en">Meunzel T. Does nitroglycerin therapy hit the endothelium? Journal of the American College of Cardiology. 2001; 38: 1102–1105.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Mayer B, Beretta M. The enigma of nitroglycerin bioactivation and nitrate tolerance: news, views and troubles. Br. J. Pharmacol. 2008; 155: 170–184.</mixed-citation><mixed-citation xml:lang="en">Mayer B, Beretta M. The enigma of nitroglycerin bioactivation and nitrate tolerance: news, views and troubles. Br. J. Pharmacol. 2008; 155: 170–184.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Gori T, Parker JD. Nitrate tolerance: a unifying hypothesis. Circulation. 2002; 106: 2510–2513.</mixed-citation><mixed-citation xml:lang="en">Gori T, Parker JD. Nitrate tolerance: a unifying hypothesis. Circulation. 2002; 106: 2510–2513.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Munzel T, Daiber A, Gori T. Nitrate Therapy: New Aspects Concerning Molecular Action and Tolerance. Circulation. 2011; 123: 2132–2144.</mixed-citation><mixed-citation xml:lang="en">Munzel T, Daiber A, Gori T. Nitrate Therapy: New Aspects Concerning Molecular Action and Tolerance. Circulation. 2011; 123: 2132–2144.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">DiFabio JM, Thomas GR, Zucco L et al. Nitroglycerin attenuates human endothelial progenitor cell differentiation, function, and survival. J. Pharmacol. Exp. Ther. 2006; 318: 117–123.</mixed-citation><mixed-citation xml:lang="en">DiFabio JM, Thomas GR, Zucco L et al. Nitroglycerin attenuates human endothelial progenitor cell differentiation, function, and survival. J. Pharmacol. Exp. Ther. 2006; 318: 117–123.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Huang L, Qiu N, Zhang C et al. Nitroglycerin enhances proliferation and osteoblastic differentiation in human mesenchymal stem cells via nitric oxide pathway. Acta. Pharmacol. Sin. 2008; 29: 580–586.</mixed-citation><mixed-citation xml:lang="en">Huang L, Qiu N, Zhang C et al. Nitroglycerin enhances proliferation and osteoblastic differentiation in human mesenchymal stem cells via nitric oxide pathway. Acta. Pharmacol. Sin. 2008; 29: 580–586.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Aicher A, Zeiher AM, Dimmeler S. Mobilizing endothelial progenitor cells. Hypertension. 2005; 45: 321–325.</mixed-citation><mixed-citation xml:lang="en">Aicher A, Zeiher AM, Dimmeler S. Mobilizing endothelial progenitor cells. Hypertension. 2005; 45: 321–325.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Лыков АП, Повещенко ОВ, Бондаренко НА, Повещенко АФ, Ким ИИ, Миллер ТВ и др. Оценка эффекта проангиогенных факторов на пролиферативную и миграционную активность клеток эндотелиальной линии EA.Hy926. Бюллетень СО РАМН. 2013;4: 23–29. Lykov AP, Poveshhenko OV, Bondarenko NA, Poveshhenko AF, Kim II, Miller TV et al. Estimation of the effect of proangiogenic factors on the proliferative and migration activities of the endothelial cells of line EA.Hy926. Bjulleten' SO RAMN. 2013; 4: 23–29.</mixed-citation><mixed-citation xml:lang="en">Лыков АП, Повещенко ОВ, Бондаренко НА, Повещенко АФ, Ким ИИ, Миллер ТВ и др. Оценка эффекта проангиогенных факторов на пролиферативную и миграционную активность клеток эндотелиальной линии EA.Hy926. Бюллетень СО РАМН. 2013;4: 23–29. Lykov AP, Poveshhenko OV, Bondarenko NA, Poveshhenko AF, Kim II, Miller TV et al. Estimation of the effect of proangiogenic factors on the proliferative and migration activities of the endothelial cells of line EA.Hy926. Bjulleten' SO RAMN. 2013; 4: 23–29.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Kaesemeyer W, Ogonowski A, Jin L et al. Endothelial nitric oxide synthase is a site of superoxide synthesis in endothelial cells treated with glyceryl trinitrate. Br. J. Pharmacol. 2000; 131: 1019–1023.</mixed-citation><mixed-citation xml:lang="en">Kaesemeyer W, Ogonowski A, Jin L et al. Endothelial nitric oxide synthase is a site of superoxide synthesis in endothelial cells treated with glyceryl trinitrate. Br. J. Pharmacol. 2000; 131: 1019–1023.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Roland CR, Mangino MJ, Flye MW. Lanthanide «blockade » of antigen-presenting cells suppresses lymphocyte proliferation by inducing nitric oxide synthesis. J. Surg. Res. 1993; 54: 401–410.</mixed-citation><mixed-citation xml:lang="en">Roland CR, Mangino MJ, Flye MW. Lanthanide «blockade » of antigen-presenting cells suppresses lymphocyte proliferation by inducing nitric oxide synthesis. J. Surg. Res. 1993; 54: 401–410.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Bamberger Т, Masson I, Mathieu J et al. Nitric oxide mediates the depression of lymphoproliferative responses following burn injury in rats. Biomed. Pharmacother. 1992; 46: 495–500.</mixed-citation><mixed-citation xml:lang="en">Bamberger Т, Masson I, Mathieu J et al. Nitric oxide mediates the depression of lymphoproliferative responses following burn injury in rats. Biomed. Pharmacother. 1992; 46: 495–500.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Ким ИИ, Повещенко ОВ, Коненков ВИ, Покушалов ЕА, Романов АБ, Бондаренко НА и др. Эффективность мобилизации CD34+ прогениторных клеток препаратом G-CSF в зависимости от ишемического анамнеза и возраста больных с хронической сердечной недостаточностью. Патология кровообращения и кардиохирургия. 2012; 1: 75–78. Kim II, Poveshhenko OV, Konenkov VI, Pokushalov EA, Romanov AB, Bondarenko NA et al. Effi cacy of the mobilization of CD34 + progenitor cells by G-CSF administrations depends at the ischemic anamnesis and age of patients with chronic heart failure. Patologija krovoobrashhenija i kardiohirurgija. 2012; 1: 75–78.</mixed-citation><mixed-citation xml:lang="en">Ким ИИ, Повещенко ОВ, Коненков ВИ, Покушалов ЕА, Романов АБ, Бондаренко НА и др. Эффективность мобилизации CD34+ прогениторных клеток препаратом G-CSF в зависимости от ишемического анамнеза и возраста больных с хронической сердечной недостаточностью. Патология кровообращения и кардиохирургия. 2012; 1: 75–78. Kim II, Poveshhenko OV, Konenkov VI, Pokushalov EA, Romanov AB, Bondarenko NA et al. Effi cacy of the mobilization of CD34 + progenitor cells by G-CSF administrations depends at the ischemic anamnesis and age of patients with chronic heart failure. Patologija krovoobrashhenija i kardiohirurgija. 2012; 1: 75–78.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Cтарикова ЭА, Амчиславский ЕИ, Соколов ДИ, Фрейдлин ИС, Полосухина ЕР, Барышников Ю. Изменение поверхностного фенотипа эндотелиальных клеток под влиянием ровоспалительных и противовоспалительных цитокинов. Медицинская иммунология. 2003; 1–2: 39–48. Ctarikova JeA, Amchislavskij EI, Sokolov DI, Frejdlin IS, Polosuhina ER, Baryshnikov AJu. Deviations of endothelial cells surface phenotype under the infl uence of pro-infl ammatory and anti-infl ammatory cytokines. Medicinskaja immunologija. 2003; 1–2: 39–48.</mixed-citation><mixed-citation xml:lang="en">Cтарикова ЭА, Амчиславский ЕИ, Соколов ДИ, Фрейдлин ИС, Полосухина ЕР, Барышников Ю. Изменение поверхностного фенотипа эндотелиальных клеток под влиянием ровоспалительных и противовоспалительных цитокинов. Медицинская иммунология. 2003; 1–2: 39–48. Ctarikova JeA, Amchislavskij EI, Sokolov DI, Frejdlin IS, Polosuhina ER, Baryshnikov AJu. Deviations of endothelial cells surface phenotype under the infl uence of pro-infl ammatory and anti-infl ammatory cytokines. Medicinskaja immunologija. 2003; 1–2: 39–48.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Бондаренко НА. Морфофункциональная характеристика эндотелиальных прогениторных клеток при хронической сердечной недостаточности: дис. … канд. биол. наук. Н., 2013: 17. Bondarenko NA. Morphofunctional characterization of endothelial progenitor cells in patients with chronic heart failure: dis. … kand. biol. nauk. N., 2013: 17.</mixed-citation><mixed-citation xml:lang="en">Бондаренко НА. Морфофункциональная характеристика эндотелиальных прогениторных клеток при хронической сердечной недостаточности: дис. … канд. биол. наук. Н., 2013: 17. Bondarenko NA. Morphofunctional characterization of endothelial progenitor cells in patients with chronic heart failure: dis. … kand. biol. nauk. N., 2013: 17.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
